Tag: analytical method validation

Documenting New Stability Data for Extension Requests

Pharmaceutical companies often seek shelf life extensions based on additional stability data generated post-approval. However, presenting this data to regulatory authorities like the EMA, USFDA, or CDSCO requires meticulous documentation, proper format, and compliance with ICH guidelines. This tutorial outlines how to collect, structure, and document new stability data effectively for extension requests. 📊 Step…

Regulatory Submissions for Shelf Life Extensions, Shelf Life and Expiry

Photostability Testing: TGA vs FDA Protocol Differences

Photostability testing plays a vital role in determining how pharmaceutical products behave when exposed to light. Regulatory bodies like the FDA and TGA both refer to ICH Q1B guidelines, but their interpretation, expectations, and execution can differ significantly. This article compares these key differences and offers regulatory-focused guidance for global pharma professionals preparing dossiers for…

Regional Guidelines: FDA, EMA, ASEAN, TGA, Regulatory Guidelines

Step-by-Step Process for Regional Stability Dossier Compilation

When preparing to submit a pharmaceutical product to multiple global markets, a well-structured regional stability dossier is essential for regulatory approval. While ICH Q1A(R2) guidelines form the foundation, each region—including the FDA (USA), EMA (Europe), ASEAN, and TGA (Australia)—has specific requirements for how stability data must be organized, justified, and presented. This tutorial provides a…

Regional Guidelines: FDA, EMA, ASEAN, TGA, Regulatory Guidelines

How to Differentiate Between OOT and OOS in Test Results

In the complex world of pharmaceutical stability testing, accurately identifying and classifying test result anomalies is essential. Two commonly misunderstood terms—Out-of-Trend (OOT) and Out-of-Specification (OOS)—often cause confusion among analysts and QA professionals. While both require rigorous documentation and investigation, they differ in origin, regulatory impact, and how they should be handled. 🔎 What Is an…

Deviation and OOS Handling in Stability Testing, Pharmaceutical Quality and Practices

Training Teams on Protocol Development Principles

Training pharmaceutical teams on protocol development principles is critical for building robust and regulatory-compliant stability programs. A well-trained team ensures consistent application of ICH guidelines, optimizes study design, and reduces submission deficiencies. Whether you’re designing stability protocols for small molecules, biologics, or new dosage forms, your team must be equipped with the knowledge and skills…

Protocols and Reports, Stability Study Protocols for Different Drug Types

Linking Protocol Design to Label Claim Shelf Life

Designing a stability study protocol isn’t just a procedural task—it directly influences the shelf life printed on the product’s label. Regulatory agencies such as the USFDA, EMA, and CDSCO expect a clear link between protocol structure and the justification for the expiry date. Without a robust design, your product may be assigned a shorter-than-necessary shelf…

Protocols and Reports, Stability Study Protocols for Different Drug Types

Understanding the CTD Format for Global Stability Submissions

The Common Technical Document (CTD) is the gold standard for global regulatory submissions, including pharmaceutical stability data. Originally developed by the ICH, the CTD streamlines communication between pharma companies and regulatory agencies by providing a harmonized dossier structure. Whether you’re submitting to USFDA, EMA, WHO, or CDSCO, understanding the CTD format—particularly Module 3.2.P.8—is essential for…

Global Harmonization of Stability Testing Regulations, Regulatory Guidelines

Comparing ICH, WHO, and FDA Stability Guidelines

Stability testing is a cornerstone of pharmaceutical quality assurance, ensuring that drugs retain their intended potency, safety, and efficacy throughout their shelf life. While global harmonization efforts have brought some consistency, significant variations still exist among leading regulatory bodies such as the USFDA, WHO, and ICH. Understanding these differences is crucial for developing a compliant…

Global Harmonization of Stability Testing Regulations, Regulatory Guidelines

Chromatographic and Spectrometric Techniques in Stability Testing

Chromatographic and Spectrometric Techniques in Stability Testing Role of HPLC, GC, and Mass Spectrometry in Pharmaceutical Stability Testing Introduction Stability testing in pharmaceuticals demands analytical techniques that are highly sensitive, selective, and reproducible to monitor even the slightest changes in drug composition over time. Among the most critical tools used in this field are High-Performance…

Analytical Techniques in Stability Studies, HPLC, GC, and Mass Spectrometry in Stability Testing

Real-Time Stability Testing Case Study: Oral Solid Dosage Forms

Real-Time Stability Testing Case Study: Oral Solid Dosage Forms Case Study: Implementing Real-Time Stability Testing for Oral Solid Dosage Forms Real-time stability testing is a regulatory requirement and quality assurance cornerstone in the pharmaceutical industry. This expert case study explores the end-to-end implementation of real-time stability testing for oral solid dosage forms (tablets and capsules),…

Real-Time and Accelerated Stability Studies, Stability Testing Types